Literature DB >> 19009252

Nomenclature and numbering of the hepatitis C virus.

Carla Kuiken1, Peter Simmonds.   

Abstract

International standardization and coordination of the nomenclature of variants of hepatitis C virus (HCV) is increasingly needed as more is discovered about the scale of HCV-related liver disease and important biological and antigenic differences that exist between variants. Consistency in numbering is also increasingly required for functional and clinical studies of HCV. For example, an unambiguous method for referring to amino acid substitutions at specific positions in NS3 and NS5B coding sequences associated with resistance to specific HCV inhibitors is essential in the investigation of antiviral treatment. Inconsistent and inaccurate numbering of locations in DNA and protein sequences is becoming a problem in the HCV scientific literature.A group of experts in the field of HCV genetic variability, and those involved in development of HCV sequence databases, the Hepatitis Virus Database (Japan), euHCVdb (France), and the Los Alamos National Laboratory (United States), convened to reexamine the status of HCV genotype nomenclature, resolve conflicting genotype or subtype names among described variants of HCV, and draw up revised criteria for the assignment of new genotypes as they are discovered in the future. They also discussed how HCV sequence databases could introduce and facilitate a standardized numbering system for HCV nucleotides, proteins, and epitopes.A comprehensive listing of all currently classified variants of HCV incorporates a number of agreed genotype and subtype name reassignments to create consistency in nomenclature. A consensus proposal was drawn up for the classification of new variants into genotypes and subtypes, which recognizes and incorporates new knowledge of HCV genetic diversity and epidemiology. The proposed numbering system was adapted from the Los Alamos HIV database, with elements from the hepatitis B virus numbering system. The system comprises both nucleotides and amino acid sequences and epitopes, and uses the full-length genome sequence of isolate H77 (accession number AF009606) as a reference. It includes a method for numbering insertions and deletions relative to this reference sequence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19009252     DOI: 10.1007/978-1-59745-394-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  58 in total

1.  Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes.

Authors:  Mouna Rajhi; Selma Mejri; Ahlem Djebbi; Soufiene Chouaieb; Imed Cheikh; Ahlem Ben Yahia; Amel Sadraoui; Walid Hammami; Msaddak Azouz; Nabil Ben Mami; Henda Triki
Journal:  Virus Genes       Date:  2013-11-23       Impact factor: 2.332

Review 2.  Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design.

Authors:  Leopold Kong; Kelli N Jackson; Ian A Wilson; Mansun Law
Journal:  Curr Opin Virol       Date:  2015-04-29       Impact factor: 7.090

Review 3.  Insights into antiviral innate immunity revealed by studying hepatitis C virus.

Authors:  Stacy M Horner
Journal:  Cytokine       Date:  2015-03-25       Impact factor: 3.861

4.  Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.

Authors:  Irfan Khan; Divya S Katikaneni; Qingxia Han; Lorena Sanchez-Felipe; Kentaro Hanada; Rebecca L Ambrose; Jason M Mackenzie; Kouacou V Konan
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1.

Authors:  Leopold Kong; Erick Giang; Justin B Robbins; Robyn L Stanfield; Dennis R Burton; Ian A Wilson; Mansun Law
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-23       Impact factor: 11.205

6.  Genetic variability and the classification of hepatitis E virus.

Authors:  Donald B Smith; Michael A Purdy; Peter Simmonds
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  Hepatitis C virus E2 envelope glycoprotein core structure.

Authors:  Leopold Kong; Erick Giang; Travis Nieusma; Rameshwar U Kadam; Kristin E Cogburn; Yuanzi Hua; Xiaoping Dai; Robyn L Stanfield; Dennis R Burton; Andrew B Ward; Ian A Wilson; Mansun Law
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

8.  Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.

Authors:  Mei Yu; Betty Peng; Katie Chan; Ruoyu Gong; Huiling Yang; William Delaney; Guofeng Cheng
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

9.  Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B.

Authors:  Qingxia Han; David Manna; Kerry Belton; Richard Cole; Kouacou V Konan
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex.

Authors:  Tinashe B Ruwona; Erick Giang; Travis Nieusma; Mansun Law
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.